Remove 2014 Remove Clinical Trials Remove History
article thumbnail

NO BRAINER: CBD AND THC FOR HEAD INJURIES

Green Relief

A 2014 study found that traumatic brain injury ( TBI ) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

THC 64
article thumbnail

Green Relief - Untitled Article

Green Relief

A 2014 study found that traumatic brain injury ( TBI ) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A Hidden Origin Story of the CBD Craze

SMPL

“There was a strong sense that this was really going to be something, if when people use these strains they have any kind of experience like the mice did in the laboratories,” said Martin Lee, a writer who at the time had been finishing a book about the social history of marijuana for Simon & Schuster. They saw the winds were shifting.”.

CBD 40
article thumbnail

Wake Network Retains CRO Santé Cannabis to Conduct Clinical Trials in Psilocybin Therapies

Cannabis Law Report

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

article thumbnail

New Frontiers in the Law of Psychedelics

Cannabis Law Report

Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinical trials are currently under way. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , Clinical Trial ID NCT03866174, available at [link].

Law 81
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

The Cannabis sativa plant has an incredibly multi-layered, rich, and versatile history of human uses for food and fibre, as well as recreational, and religious and spiritual purposes throughout the world (McPartland and Hegman 2018 ; Aldrich 1997 ; Touw 1981 ; Li 1974 ; Bonini et al. 2018 ; Frankhauser 2008 ). 5), Medical Observer ( n ?

article thumbnail

Global Legal Cannabis Markets Analysis 2021-2028 by Sources (Marijuana, Hemp), End-use (Recreational, Medical), Derivatives (CBD, THC) – ResearchAndMarkets.com

Cannabis Law Report

Global Legal Cannabis Industry: History of Medical Use of Cannabis. Global Legal Cannabis Industry: History of Industrial Use of Cannabis. Global Legal Cannabis Industry: Number of Clinical Trials, By Region. Marijuana Market Estimates And Forecasts, 2014 – 2028 (USD Million). Market Segmentation.